Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T17:30:40.196Z.
Calculation as of: 2026-10-06T17:30:40.196Z.
Quote observation: 2026-10-06T17:30:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6c02d81e284155bdcda1783dec911e9c0a395e203238f61c1cccf60d236910ce
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Axsome Therapeutics, Inc.
Market Cap
$8.96B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.98B
Operating Cash Flow Yield
2.12%
TTM Avg
0.25%
3Y Avg
0.26%
5Y Avg
0.26%
Market Cap
$8.79B
Operating Cash Flow Yield
1.49%
TTM Avg
1.10%
3Y Avg
5.10%
5Y Avg
5.10%
Market Cap
$8.69B
Operating Cash Flow Yield
N/A
TTM Avg
2.18%
3Y Avg
2.18%
5Y Avg
2.46%
Market Cap
$9.28B
Operating Cash Flow Yield
2.05%
TTM Avg
1.91%
3Y Avg
2.90%
5Y Avg
2.85%
Market Cap
$8.57B
Operating Cash Flow Yield
N/A
TTM Avg
3.45%
3Y Avg
3.46%
5Y Avg
3.46%
Market Cap
$9.33B
Operating Cash Flow Yield
5.48%
TTM Avg
4.05%
3Y Avg
2.43%
5Y Avg
1.96%
Market Cap
$8.40B
Operating Cash Flow Yield
52.06%
TTM Avg
28.44%
3Y Avg
24.26%
5Y Avg
22.51%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | $8.96B | N/A | N/A | N/A | N/A |
| Bruker Corporation (BRKRP)vs › | $8.98B | 2.12% | 0.25% | 0.26% | 0.26% |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.79B | 1.49% | 1.10% | 5.10% | 5.10% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.69B | N/A | 2.18% | 2.18% | 2.46% |
| Bruker Corporation (BRKR)vs › | $9.28B | 2.05% | 1.91% | 2.90% | 2.85% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.57B | N/A | 3.45% | 3.46% | 3.46% |
| Insulet Corp. (PODD)vs › | $9.33B | 5.48% | 4.05% | 2.43% | 1.96% |
| Vaxcyte, Inc. (PCVX)vs › | $9.43B | N/A | N/A | N/A | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.40B | 52.06% | 28.44% | 24.26% | 22.51% |
| Krystal Biotech, Inc. (KRYS)vs › | $9.52B | 2.86% | 2.60% | 2.63% | 2.63% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
